氟立班丝氨治疗女性性欲减退症
Flibanserin for Treating Hypoactive Sexual Desire Disorder.
作者信息
Sang Jae Hong, Kim Tae-Hee, Kim Soo Ah
机构信息
Department of Obstetrics and Gynecology, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi, Korea.
Department of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, Bucheon, Korea.
出版信息
J Menopausal Med. 2016 Apr;22(1):9-13. doi: 10.6118/jmm.2016.22.1.9. Epub 2016 Apr 26.
There have been several products developed for male sexual dysfunction. However, developing agents for female sexual dysfunction is lagging behind for various reasons. Sildenafil citrate (Viagra) and Tadalafil (Cialis), which have been prescribed for male sexual function disorders, are known to act on vessels.[1] On the other hand, flibanserin is thought to act on brain. Flibanserin has been approved by U. S. Food and Drug Administration (FDA) for treatment of hypoactive sexual desire disorder (HSDD) of premenopausal women in 2015, and is expected to be released in South Korea soon. Authors wrote this article to acknowledge flibanserin to sexologists for females or physicians for menopausal medicine, so that this agent can be safely used for females who have HSDD.
已经开发出了几种用于治疗男性性功能障碍的产品。然而，由于各种原因，用于治疗女性性功能障碍的药物研发滞后。已被用于治疗男性性功能障碍的枸橼酸西地那非（万艾可）和他达拉非（希爱力），已知作用于血管。[1] 另一方面，氟班色林被认为作用于大脑。氟班色林于2015年获得美国食品药品监督管理局（FDA）批准，用于治疗绝经前女性性欲减退障碍（HSDD），预计很快将在韩国上市。作者撰写本文是为了向女性性学家或绝经医学领域的医生介绍氟班色林，以便该药物能安全地用于患有HSDD的女性。
Zotero 插件